INS and type 2 diabetes mellitus: Most of the included studies determined participants’ T2DM or IR status using objective biochemical measures such as HbA1c, the oral glucose tolerance test (OGTT), fasting blood/plasma glucose (FBG/FPG), or fasting insulin (FINS), which minimizes misclassification bias.